Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

Allergan Recruits Celebrities to Preventable Blindness Marketing Campaign

XTALKS VITALS NEWS

Allergan

The commercial featuring Ventimiglia encourages people to post a photo of their eyes on social media channels using the hashtag, #EYEPIC and tag friends in the hopes that they’ll do the same.

Share this!

July 13, 2017 | by Sarah Hand, M.Sc.

Milo Ventimiglia, best known for his portrayal of Jess Mariano in “Gilmore Girls,” has joined actress Alexandra Daddario and football player Victor Cruz to promote Allergan’s See America social media campaign. The disease awareness ads featuring the celebrities are designed to help people become more mindful of preventable causes of blindness and what the general public can do to help this cause.

The commercial featuring Ventimiglia encourages people to post a photo of their eyes on social media channels using the hashtag, #EYEPIC and tag friends in the hopes that they’ll do the same. Through their See America initiative, Allergan has committed to donate $10 to the American Foundation for the Blind for every post using the hashtag, up to $50,000.

“Sight is one of life’s most amazing and delicate gifts,” said Jag Dosanjh, SVP of US Eye Care at Allergan. “We’re launching #EyePic on social media to spread the word about preventable blindness, in a forum where people can easily join the fight. With the help of Milo, Victor, Alexandra and the many Americans who will be posting their own #EyePic, we will encourage proactive eye care and communicate important facts about preventable blindness in America.”



According to Allergan, over 20 million people in the US suffer some form of vision loss. As a national non-profit organization, the American Foundation for the Blind helps provide technology and other resources to people living with blindness.

“We are grateful for Allergan’s support,” said Kirk Adams, President and CEO of the American Foundation for the Blind. “The American Foundation for the Blind is committed to creating a world with no limits for millions of Americans who are blind or visually impaired, like myself; and we are heartened that Allergan is supporting our mission.”

It’s no surprise that Allergan is spearheading a disease awareness campaign for vision loss; the company is a global leader in the eye care space, marketing produces such as Restasis for dry eye disease and Lumigan for glaucoma.

Earlier this year, Allergan launched a dry eye disease awareness campaign called Eyepowerment. No stranger to direct-to-consumer (DTC) ad campaigns featuring celebrities, drugmaker rival Shire previously launched its “eyelove” campaign featuring actress Jennifer Aniston.


Keywords:  Disease Awareness, DTC Advertising, Eye Disease


| NEXT ARTICLE | MORE NEWS | BLOGS | VIDEOS | POLLS & QUIZZES | WEBINARS |

Share this with your colleagues!

MORE NEWS
Researchers Identify Role of ApoE4 Gene as Possible Drug Target in Alzheimer’s Disease

September 21, 2017 - A team of neurology researchers at Washington University School of Medicine in St. Louis have found that in the presence of the ApoE4 protein, another protein known as tau forms tangles in the brain which contributes to neuronal damage characteristic of Alzheimer’s disease.

Featured In: Life Science News


New Guidelines Address CAR-T Immunotherapy Toxicities to Prevent Patient Deaths

September 20, 2017 - Clinicians at The University of Texas MD Anderson Cancer Center have published new guidelines in the journal, Nature Reviews Clinical Oncology, which could help in the management of these toxicities.

Featured In: Biotech News, Drug Safety News


Microneedle Skin Patch Could Treat Common Metabolic Disorders

September 19, 2017 - Researchers at Columbia University Medical Center (CUMC) and the University of North Carolina have developed a microneedle skin patch impregnated with a drug capable of converting white fat into calorie-burning brown fat.

Featured In: Medical Device News


LEAVE A COMMENT
 
  
THE XTALKS VITALS INDUSTRY BLOG

Five Reasons Why Toronto is Emerging as a Major Life Sciences Hub

REGISTER FOR THESE WEBINARS

Development and Manufacture of Highly Potent API Drug Products Throughout the Clinical Phases


Innovation through Integration – Providing Next Generation Biomedical Devices and Interconnects


Clinical Payments Case Studies: Improving Efficiency, Cash Management, and Compliance


Why Phase 3 Trials Fail: Oncology Case Studies and Lessons Learned


Copyright © 2016-2017 Honeycomb Worldwide Inc.